LifeSciences BC > About LSBC > Board of Directors

Print Friendly

Board of Directors

LifeSciences BC is governed by a Board of Directors, whose members represent British Columbia’s biopharmaceutical, biotechnology, medical devices, digital health and greater life sciences community. Our board provides guidance, sets policy and ensures that the organization operates effectively in achieving its mandate, which is to foster the economic development of B.C.’s life sciences industry.

Chair

Gordon McCauley – Partner, NDI Capital

Vice Chair

James P. Hatton Q.C. – Partner, Technology Group, Farris, Vaughan, Wills & Murphy LLP

Past Chair

Doug Janzen – Founder & Managing Director, Northview Ventures

Treasurer

Ian Heine – Partner, PwC

Secretary

Paul V. Drohan – President & CEO, LifeSciences BC

Directors

Dr. Brendan Byrne – VP & General Manager, Provider Solutions, TELUS Health

 

Robin Ciceri – President, The Research Universities’ Council of BC

 

Dr. Allen Eaves – President & CEO, STEMCELL Technologies Inc.

 

Nancy Harrison – Chief Business Officer, MSI Methylation Sciences Inc.

 

Alexei Marko – CEO & Director, Neovasc Inc.

 

Dr. Gavin Stuart – Dean, Faculty of Medicine, University of British Columbia

 

James Taylor – CEO, Precision Nanosystems Inc.

 

Dr. Paul Terry – President & CEO, PHEMI Health Systems

 

Dr. Alan E. Winter – President and CEO, Genome British Columbia

 

Observers to the Board

Joseph Garcia – Partner, Blake, Cassels & Graydon LLP

 

Hector MacKay-Dunn, J.D. Q.C. – Senior Partner, Farris, Vaughan, Wills & Murphy LLP

 

BIOTECHNOLOGY INDUSTRY